India's Cipla launches etanercept biosimilar

MUMBAI, April 17 Wed Apr 17, 2013 7:17am EDT

Related Topics

MUMBAI, April 17 (Reuters) - Indian drugmaker Cipla Ltd said on Wednesday it has launched etanercept biosimilar in India under the brand name Etacept.

The drug, used to treat rheumatic disorders, is manufactured by China's Shanghai CP Guojian Pharmaceutical Co and would be sold by Cipla in India through a partnership, it said in a statement. (Reporting by Kaustubh Kulkarni; Editing by Bijoy Koyitty)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.